Balance
Pipeline by Development Stage
On Market (2)
Approved therapies currently available
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Showing 15 of 37 trials with date data
Clinical Trials (37)
Total enrollment: 8,549 patients across 37 trials
Insomnia Prevalence and Treatment Impact on Systemic Hypertension
Ramelteon for Treatment of Adult Patients With ADHD-Related Insomnia
Ramelteon as an Adjunct Therapy in Non-Diabetic Patients With Schizophrenia
Ramelteon for the Treatment of Insomnia and Mood Stability in Patients With Euthymic Bipolar Disorder
Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
Treating Chronic Insomnia in Breast Cancer Patients
A Safety and Efficacy Study of Ramelteon Tablets for Sublingual Administration (TAK-375SL) in the Maintenance Treatment of Bipolar 1 Disorder
Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder
Efficacy and Safety of Ramelteon Sublingual in Adult Patients With Acute Depressive Episodes Associated With Bipolar I Disorder
Add-On Ramelteon in Bipolar I Disorder With Clinically Significant Sleep Disturbance
Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia
Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375)
Safety and Efficacy of Ramelteon in Adults With Chronic Insomnia
Efficacy of Ramelteon in Adults With Chronic Insomnia
Efficacy of Ramelteon in Subjects With Chronic Insomnia
Study of Efficacy of Ramelteon in Adults With Chronic Insomnia
Efficacy of Ramelteon on Transient Insomnia in Healthy Adults
Ramelteon in Adults With Chronic Insomnia
Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia
A Study of a Melatonin Receptor Agonist to Prevent Migraine
Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome
Safety and Efficacy of Ramelteon and Doxepin in Subjects With Chronic Insomnia
Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease
Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea
Behavioral and Subjective Efficacy of Ramelteon in Subjects With a History of Polydrug Abuse
Efficacy and Safety of Ramelteon on Chronic Insomnia
Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults
Effects of Ramelteon on Driving Ability
Villency-Proof of Action: Foot Device, Balance and Sway, Kinematics of Walking
Ramelteon 8 mg Tablets Specified Drug-use Survey: <Long-term Survey on Insomnia Accompanied by Difficulty Falling Asleep> - Transitional Survey From the Preceding Drug-use Survey -
Clinical Management of Neuropathic Pain With Ramelteon
Ramelteon for Sleep Initiation Insomnia in Individuals With Panic Disorder Who Are Also on Escitalopram for Anxiety
Magnetoencephalographic (MEG) Localization of Ramelteon's Effects on Brain Function and Cortical Arousal in Insomnia
Ramelteon for a Nap Prior to a Night Shift